Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recombinant allergens for specific immunotherapy].

Marek L Kowalski1, Anna Balwierz

  • 1Katedra i Zakład Immunologii Klinicznej Uniwersytetu Medycznego w Łodzi.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|October 4, 2003
PubMed
Summary

Recombinant allergens are revolutionizing immunotherapy by offering safer and more effective treatments for allergies. These advanced allergen variants and epitopes are reshaping the approach to allergic disease management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of miRNA Expression in Patients With NSAID-Exacerbated Respiratory Disease.

Allergy, asthma & immunology research·2025
Same author

Overestimation of asthma control and misperception of the place of short-acting β2-agonists in asthma management: a prospective, real-world study among physicians in Poland.

The Journal of asthma : official journal of the Association for the Care of Asthma·2025
Same author

Predictors of excessive short-acting β<sub>2</sub>-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.

Postepy dermatologii i alergologii·2024
Same author

miRNA expression in serum and PBMCs isolated from middle-aged and elderly patients during asthma exacerbation.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2023
Same author

Allergy clinic patients' drug hypersensitivity.

Allergologia et immunopathologia·2022
Same author

Physical exercise, immune response, and susceptibility to infections-current knowledge and growing research areas.

Allergy·2022

Area of Science:

  • Immunology
  • Biotechnology
  • Allergology

Context:

  • Recombinant allergens are increasingly integrated into clinical practice for allergen-specific immunotherapy.
  • Existing allergen variants and epitopes demonstrate potential for influencing allergic pathomechanisms.

Purpose:

  • To explore the role and efficacy of recombinant allergens in modern immunotherapy.
  • To highlight the impact of novel allergen variants and epitopes on allergic disease treatment.

Summary:

  • Recombinant allergens are established in clinical settings for allergen-specific immunotherapy.
  • Specific allergen variants and epitopes have shown promise in improving safety and efficacy.
  • Current understanding of recombinant allergens opens new therapeutic avenues in immunotherapy.

Related Experiment Videos

Impact:

  • Recombinant allergens offer a novel and potentially more effective approach to immunotherapy.
  • Advances in allergen variants and epitopes are influencing the understanding and treatment of allergic processes.
  • This evolving field suggests a paradigm shift in managing allergic conditions.